Drug misuse and dependency

Services

Drugs Test 1 (DT1) form
Form for the testing of specified class A drugs on persons ages 18 or over.
NDTMS: community combined review forms
Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.
NDTMS: secure setting outcomes forms
Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.

Controlled drugs list
- Guidance
- 2 December 2019
- Home Office
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
- Guidance
- 6 January 2021
- Public Health England and Department of Health and Social Care
Precursor chemical licensing
- Detailed guide
- 31 December 2020
- Home Office
Drug misuse and dependence: UK guidelines on clinical management
- Guidance
- 15 December 2017
- Department of Health and Social Care
ASSIST-Lite screening tool: how to use
- Guidance
- 5 January 2021
- Public Health England

Extra help for rough sleepers with drug and alcohol dependency
- 14 December 2020
- Ministry of Housing, Communities & Local Government, Department of Health and Social Care, and Public Health England
- Press release
Response to the ACMD report on the misuse of fentanyl and fentanyl analogues
- 20 October 2020
- Home Office
- Correspondence
Response to the ACMD report on novel benzodiazepines
- 8 September 2020
- Home Office and Advisory Council on the Misuse of Drugs
- Correspondence
Three new benzodiazepines to become Class C drugs
- 8 September 2020
- Home Office
- News story
ACMD work programme 2020 to 2022: commissioning letter
- 12 August 2020
- Home Office
- Correspondence

Prescribed medicines review: report
- 3 December 2020
- Public Health England
- Research
United Kingdom drug situation: Focal Point annual report
- 2 December 2020
- Public Health England, Home Office, Welsh Government, The Scottish Government, Public Health Wales, and Department of Health (Northern Ireland)
- Research
Substance misuse treatment for adults: statistics 2019 to 2020
- 26 November 2020
- Public Health England
- National statistics
Assessment of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds
- 20 November 2020
- Advisory Council on the Misuse of Drugs
- Research
Novel benzodiazepines: prevalence and harms in the UK
- 16 November 2020
- Advisory Council on the Misuse of Drugs
- Research

Independent review of drugs: call for evidence, part 2
- 2 July 2020
- Department of Health and Social Care
- Closed consultation
- Date closed 07 August 2020
NDTMS annual reports and methodology: proposed changes
- 24 September 2019
- Public Health England
- Consultation outcome
- Date closed 25 August 2019
ACMD ageing cohort of drug users report: government response
- 3 October 2019
- Department of Health and Social Care
- Policy paper
Drug related harms in homeless populations: government response
- 19 September 2019
- Ministry of Housing, Communities & Local Government and Department of Health and Social Care
- Policy paper
Drugs policy and medicinal cannabis report: government response
- 6 September 2019
- Department of Health and Social Care
- Policy paper

Standard Operating Procedure for using evidence in ACMD reports
- 26 March 2020
- Advisory Council on the Misuse of Drugs
- Corporate report
Commissioning impact on drug treatment
- 6 September 2017
- Advisory Council on the Misuse of Drugs
- Corporate report
Drug strategy 2016: development review
- 14 July 2017
- Advisory Council on the Misuse of Drugs
- Corporate report
Psychoactive Substances Bill: evaluation review
- 14 July 2017
- Advisory Council on the Misuse of Drugs
- Corporate report
Methiopropamine: a review of the evidence of use and harm
- 16 June 2017
- Advisory Council on the Misuse of Drugs
- Corporate report

Show more organisations